R. Jamal

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Matthew D. Hellmann, T. W. Kim, Chul‐min Lee et al. · Annals of Oncology · 2019 · 188 citations · Full text

Phase Ib Study, Solid Tumors, Medicine +7

Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC)

Scott Antonia, Julie R. Brahmer, Samir N. Khleif et al. · Annals of Oncology · 2016 · 38 citations

Phase 1/2, Oncology, Medicine +7

LBA44 Lenvatinib (len) plus pembrolizumab (pembro) for advanced melanoma (MEL) that progressed on a PD-1 or PD-L1 inhibitor: Initial results of LEAP-004

Ana Arance, Steven O’Day, Luis de la Cruz‐Merino et al. · Annals of Oncology · 2020 · 25 citations

Pd-l1 Inhibitor, Medicine, Melanoma +8

Improving Growth, Digestive and Antioxidant Enzymes and Immune Response of Juvenile Grass Carp (Ctenopharyngodon idella) by Using Dietary Spirulina platensis

Mehwish Faheem, R. Jamal, Nadia Nazeer et al. · Fishes · 2022 · 16 citations · Full text

Nutrition, Spirulina Platensis, Antioxidant Enzymes +20

Permanent renal failure induced by pentastarch

R. Jamal, Marc Ghannoum, Judith Naud et al. · Clinical Kidney Journal · 2008 · 15 citations · Full text

Glomerular Disease, Renal Pathology, Renal Inflammation +16